Get Started

GMED

NYSE Globus Medical Inc Class A
Oct 30, 2026 · 1:54 AM ET EOD Market Closed

$82.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $82.91, $0.52 below the day’s high of $83.43

YTD change
-5.04%
vs 20-day SMA
+7.01%
vs 200-day SMA
-0.83%

Price ranges

Previous day
$80.23 $81.75
open $80.47 close $81.26
+$0.79 (+0.98%)
Today
$81.79 $83.43
open $82.37 now $82.91
+$0.54 (+0.66%)
Past week
$78.46 $82.02
from $78.68 now $82.91
+$4.23 (+5.38%)
Past month
$72.54 $82.02
from $74.90 now $82.91
+$8.01 (+10.69%)
This year
$72.54 $101.40
from $87.31 now $82.91
-$4.40 (-5.04%)

Price & Performance

-4.88 (-5.56%) / 6M

$71.89$78.85$85.82$92.78Apr 29Jul 30Oct 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 18.2% away from all-time highs of $101.40
  • GMED is down 5% since the beginning of the year
  • GMED is up 35% over the past 12 months
  • GMED is up 11% over the past 1 month
  • 7% of all GMED investors are betting against GMED
  • Number of investors short GMED has gone up 24% versus last month

GMED reads very good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +34.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $1.34
Earnings momentum -12.0% Quarterly EPS growth
Quarterly change -12.0%

Valuation

P/E ratio 20.74
Enterprise value $10.7B
Beta 0.79

Balance sheet & scale

Income$535.4K
Revenue$3.1B
Cash$595.1M
Debt$111.9K
Income / Debt 4.78×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $9.3B

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. The firm classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in 2003 and is headquartered in Audubon, PA.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $35.07 +1.45%
BDX Becton, Dickinson and Company $198.34 +1.63%
DXCM DexCom, Inc. $79.93 +1.67%
WST West Pharmaceutical Services, Inc. $416.67 +3.23%
MDLN Medline, Inc. Class A $32.00 -1.14%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.